These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9789143)

  • 1. Chemoprevention: a new way to face colorectal cancer in ulcerative colitis.
    Biasco G; Zannoni U
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):426-7. PubMed ID: 9789143
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence.
    Diculescu M; Ciocîrlan M; Ciocîrlan M; Piţigoi D; Becheanu G; Croitoru A; Spanache S
    Rom J Gastroenterol; 2003 Dec; 12(4):283-6. PubMed ID: 14726972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ulcerative colitis. Cancer prevention].
    Schmiegel W; Pox C; Kroesen A
    Z Gastroenterol; 2004 Sep; 42(9):1014-8. PubMed ID: 15455276
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoprevention of colorectal cancer in ulcerative colitis.
    Thomson A
    Intern Med J; 2006 Aug; 36(8):540; author reply 541. PubMed ID: 16866668
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemoprevention for colorectal cancer: some progress but a long way to go.
    Lance P
    Gastroenterology; 2008 Jan; 134(1):341-3. PubMed ID: 18166360
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoprevention of colorectal cancer in ulcerative colitis.
    Croog VJ; Ullman TA; Itzkowitz SH
    Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the cancer risk in ulcerative colitis.
    Juhasz ES; Neill ME
    N Z Med J; 1992 Feb; 105(928):59-60. PubMed ID: 1542476
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of colorectal cancer.
    Purnak T; Ozaslan E; Efe C
    N Engl J Med; 2010 Apr; 362(13):1246; author reply 1246-7. PubMed ID: 20364461
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer surveillance in ulcerative colitis.
    Chambers WM; Warren BF; Jewell DP; Mortensen NJ
    Br J Surg; 2005 Aug; 92(8):928-36. PubMed ID: 16034807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal cancer in ulcerative colitis.
    Broström O; Karlen P; Löfberg R
    Gut; 1991 Jun; 32(6):721-3. PubMed ID: 2060886
    [No Abstract]   [Full Text] [Related]  

  • 13. [5-aminosalicylic acid and cancer prophylaxis?].
    Thomsen OO
    Ugeskr Laeger; 2006 May; 168(21):2047. PubMed ID: 16768920
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mesalazine in ulcerative colitis. Fewer cases of colorectal carcinoma].
    MMW Fortschr Med; 2002 Feb; 144(9):51. PubMed ID: 11921656
    [No Abstract]   [Full Text] [Related]  

  • 15. The risk of colorectal cancer in ulcerative colitis in a population-based setting.
    Sprung D
    Gastroenterology; 2006 Aug; 131(2):684; author reply 684-5. PubMed ID: 16890631
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical guidelines for the diagnosis and treatment of chronic ulcerative colitis (CUC). Treatment of severe CUC and followup approach for cancer risk assessment].
    Rev Gastroenterol Mex; 2007; 72(3):309-19. PubMed ID: 18402224
    [No Abstract]   [Full Text] [Related]  

  • 17. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M; Moum B
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice.
    Carrier J; Medline A; Sohn KJ; Choi M; Martin R; Hwang SW; Kim YI
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1262-7. PubMed ID: 14652292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of therapy with 5-aminosalicylic acid in chemoprevention of colorectal carcinoma in ulcerative colitis].
    Herfarth H; Schölmerich J
    Z Gastroenterol; 2000 Nov; 38(11):923-5. PubMed ID: 11132541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Colitis-associated cancer in ulcerative colitis -pathological condition and chemoprevention].
    Kusunoki R; Kuwai T; Ishihara S
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(11):947-956. PubMed ID: 33177256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.